C O M M U N I C A T I O N S
Table 1. Prins Cyclizations of Enecarbamates
Scheme 3
(E)-enecarbamates is then transferred with high fidelity to afford
the frequently observed and biologically significant all-cis-2,3,6-
trisubstituted tetrahydropyran substructures of naturally occurring
compounds. This methodology facilitated an exceptionally concise
formal total synthesis of the nuclear export inhibitor (+)-ratjadone
A, and its further development and application is underway.
Acknowledgment. We appreciate the financial support provided
by the National Institutes of Health (GM28553).
Supporting Information Available: Spectroscopic data and ex-
perimental details for the preparation of all new compounds (PDF).
This material is available free of charge via the Internet at http://
pubs.acs.org.
References
(1) Ratjadone A: (a) Schummer, D.; Gerth, K.; Reichenbach, H.; Ho¨fle, G.
Liebigs Ann. 1995, 685. (b) Gerth, K.; Schummer, D.; Ho¨fle, G.; Irschik,
H.; Reichenbach, H. J. Antibiot. 1995, 973. Ratjadones B-D: (c) Ko¨ster,
M.; Lykke-Anderson, S.; Elnakady, Y. A.; Gerth, K.; Washausen, P.;
Ho¨fle, G.; Sasse, F.; Kjems, J.; Hauser, H. Exp. Cell Res. 2003, 321.
Kendomycin: (d) Bode, H. B.; Zeeck, A. J. Chem. Soc., Perkin Trans. 1
2000, 323. FR901464: (e) Nakajima, H.; Sato, B.; Fujita, T.; Takase, S.;
Terano, H.; Okuhara, M. J. Antibiot. 1996, 49, 1196. Phorboxazoles A,
B: (f) Searle, P. A.; Molinski, T. F.; Brzezinski, L. J.; Leahy, J. W. J.
Am. Chem. Soc. 1996, 118, 9422. Sorangicin A: (g) Jansen, R.; Wray,
V.; Irschik, H.; Reichenbach, H.; Ho¨fle, H. Tetrahedron Lett. 1985, 26,
6031. Lasonolide A: (h) Horton, P. A.; Koehn, F. E.; Longley, R. E.;
McConnell, O. J. J. Am. Chem. Soc. 1994, 116, 6015.
(2) For a recent review of Prins cyclizations, see: Snider, B. B. ComprehensiVe
Organic Synthesis; Trost, B. M., Ed.; Pergamon Press: Oxford, UK, 1991;
Vol. 2, p 527.
(3) For selected recent examples of vinyl silanes, see: (a) Viswanathan, G.
S.; Yang, J.; Li, C. J. Org. Lett. 1999, 1, 993. (b) Dobbs, A. P.; Martinovic,
S. Tetrahedron Lett. 2002, 43, 7055. Allyl silanes, see: (c) Roush, W.
R.; Dilley, G. J. Synlett 2001, 955. (d) Leroy, B.; Marko´, I. E. J. Org.
Chem. 2002, 67, 8744. (e) Yu, C. M.; Lee, J. Y.; So, B.; Hong, J. Angew.
Chem., Int. Ed. 2002, 41, 161. (f) Keck, G. E.; Covel, J. A.; Schiff, T.;
Yu, T. Org. Lett. 2002, 4, 1189.
(4) Completed natural products syntheses include the following. Apicularen:
(a) Su, Q.; Panek, J. S. J. Am. Chem. Soc. 2004, 126, 2425. Catechols 1
and 2: (b) Crosby, S. R.; Harding, J. R.; King, C. D.; Parker, G. D.; Willis,
C. L. Org. Lett. 2002, 4, 3407. Leucascandrolide: (c) Kopecky, D. J.;
Rychnovsky, S. D. J. Am. Chem. Soc. 2001, 123, 8420.
a >95:5 by 1H NMR analysis of crude reaction mixture. See Supporting
Information for stereochemical assignments based upon diagnostic NOEs.
To that end, the known optically pure epoxide 5 was prepared
by a Sharpless asymmetric epoxidation of divinylcarbinol9 followed
by silylation and then subjected to the vinyl anion derivative of
enecarbamate 1 to afford the key homoallylic alcohol 6. Treatment
of enecarbamate 6 with crotonaldehyde in the presence of InCl3
furnished the tetrahydropyranone 7 as a single diastereomer in good
yield (84%). Reduction of pyranone 7 with sodium borohydride
gave exclusively the undesired all-cis alcohol 8b whose Mitsunobu
inversion was problematic due to competing elimination. Accord-
ingly, a variety of ketone reducing agents were surveyed, and it
was found that triisobutylaluminum hydride produced a nearly equal
amount of stereoisomeric alcohols 8a and 8b. The undesired alcohol
8b could be readily recycled by oxidation to pyranone 7. The desired
alcohol 8a was deprotected to afford diol 9 whose spectral properties
were identical with those reported by Kalesse,8a which thereby
constitutes a formal total synthesis of (+)-ratjadone A.
(5) Preparation of the 2,3,5,6-tetrasubstituted tetrahydropyran subunit by a
Petasis-Ferrier rearrangement in a total synthesis of phorboxazole is an
exception; see: (a) Smith, A. B., III; Minbiole, K. P.; Verhoest, P. R.;
Schelhaas, M. J. Am. Chem. Soc. 2001, 123, 10942. For other examples
of Prins cyclizations leading to all-cis-2,3,6-trisubstituted tetrahydropyrans,
see: (b) Patterson, B.; Rychnovsky, S. D. Synlett 2004, 543. (c) Barry,
C. J.; Crosby, S. R.; Harding, J. R.; Hughes, R. A.; King, C. D.; Parker,
G. D.; Willis, C. L. Org. Lett. 2003, 5, 2429. (d) Hart, D. J.; Bennett, C.
E. Org. Lett. 2003, 5, 1499. (e) Rychnovsky, S. D.; Marumoto, S.; Jaber,
J. J. Org. Lett. 2001, 3, 3815. (f) Rychnovsky, S. D.; Thomas, C. R. Org.
Lett. 2000, 2, 1217. (g) Marko´, I. E.; Chelle, F. Tetrahedron Lett. 1996,
38, 2895. In addition, several of the tetrahydropyrans enumerated in ref
3d above are all-cis-2,3,6-trisubstituted but possess a C(3) oxygen rather
than a carbon substituent.
(6) Bach, T.; Schro¨der, J. J. Org. Chem. 1999, 64, 1265.
(7) (a) Whisler, M. C.; Soli, E. D.; Beak, P. Tetrahedron Lett. 2000, 41, 9527.
(b) Comins, D. L.; Weglarz, M. A. J. Org. Chem. 1988, 53, 4437.
(8) (a) Bhatt, U.; Christmann, M.; Quitschalle, M.; Claus, E.; Kalesse, M. J.
Org. Chem. 2001, 66, 1885. (b) Kalesse, M.; Christmann, M.; Bhatt, U.;
Quitschalle, M.; Claus, E.; Saeed, A.; Buzlaff, A.; Kasper, C.; Haustedt,
L. O.; Hofer, E.; Scheper, T.; Beil, W. ChemBiochem 2001, 2, 709. (c)
Williams, D. R.; Ihle, D. C.; Plummer, S. V. Org. Lett. 2001, 3, 1383.
(9) Romero, A.; Wong, C. H. J. Org. Chem. 2000, 65, 8264.
JA046940R
In conclusion, we have shown that enecarbamates are excellent
terminating groups for Prins cyclizations. A noteworthy feature of
this methodology is the easy, stereoselective construction of the
cyclization precursors by alkylation of metalated (E)-enecarbamates
with epoxides. The stereochemistry of the resultant trisubstituted
9
J. AM. CHEM. SOC. VOL. 126, NO. 39, 2004 12217